page_banner

Products

HEPPSO Cas:68399-78-0 4 -(2 -Hydroxyethyl) piperazine -1 -(2-hydroxypropanesulfonic acid) 99% white powder

Short Description:

Catalog Number: XD90098
Cas: 68399-78-0
Molecular Formula: C9H20N2O5S·xH2O
Molecular Weight: 268.33
Availability: In Stock
Price:
Prepack: 100g USD40
Bulk Pack: Request Quote

Product Detail

Product Tags

Catalog Number XD90098
Product Name HEPPSO
CAS 68399-78-0
Molecular Formula C9H20N2O5S·xH2O
Molecular Weight 268.33
Storage Details Ambient
Harmonized Tariff Code 29335995

Product Specification

Appearance white powder
Assay >99%
pH 5.4 - 6.0
A260 (0.1M water) <0.040
A280 (0.1M water) <0.020
Solubility 0.1M water Clear, Colourless Solution
Infrared Complies

One of the factors driving the growth of the pharmaceutical intermediate market over the forecast period is the increased burden of various diseases such as infectious diseases, chronic diseases, and others. This is expected to cause a surge in the demand for pharmaceutical intermediates over the forecast period. As per the Centers for Disease Control and Prevention 2017 report, there were around 16.8 million physician visits for infectious and parasitic diseases. Various research and development activities carried by pharmaceutical companies will further support the growth of pharmaceutical intermediates market and help companies to expand their therapeutic area segment, which, in turn, will promote the growth of the pharmaceutical intermediate market. Furthermore, patent expiry is also a major factor supporting the growth of the pharmaceutical intermediate market. Moreover, high spending on research and development activities and constant demand for new and innovative therapies are e xpected to promote the growth of pharmaceutical intermediates market over the forecast period. However, stringent regulatory policies are expected to slow down the growth of the pharmaceutical intermediates market in the coming years

Pharmaceutical intermediates are classified on the basis of product type, application, and distribution channel. On the basis of product type, pharmaceutical intermediates market is segmented into GMP and non GMP. On the basis of application, pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. On the basis of the distribution channel, pharmaceutical intermediates are segmented into direct sales and distributors.

The Asia Pacific is expected to be the third largest and fastest growing region over the forecast period, owing to the rise in the occurrence of diseases, increasing investments in healthcare sector and infrastructure, coupled with the increased demand for pharmaceuticals. The developing countries such as China and India have large production units of the pharmaceuticals intermediates and are expected to promote the growth of pharmaceutical intermediate market over the forecast period.

Latin America and the Middle East and Africa pharmaceutical intermediates market is expected to grow moderately over the forecast period due to the increased prevalence of various diseases and increased use of pharmaceuticals. Furthermore, supportive government initiatives are further expected to support the growth of pharmaceutical intermediates in the near future.


  • Previous:
  • Next:

  • Close

    HEPPSO Cas:68399-78-0 4 -(2 -Hydroxyethyl) piperazine -1 -(2-hydroxypropanesulfonic acid) 99% white powder